Home / Auditor changes / Benitec Biopharma Inc.

3/5Benitec Biopharma Inc. (BNTC): Auditor change

Filed 2026-09-24 路 Form 8-K 路 Accession 0001193125-26-401110

Verified excerpt

"As further outlined below, as a result of such process, the Company appointed Ernst & Young LLP ("EY")."

Quoted from the filing. Source

What this means

The company changed its outside auditor (8-K Item 4.01). A dismissal or resignation, especially near an annual report or with reported disagreements, is a warning sign. Changes caused by audit firms merging are usually routine.

Type: dismissed
Disagreements reported: no

Read the original filing on SEC.gov →

Not investment advice. Automated summary; verify against the filing.

Get the weekly "Red Flags" newsletter

The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.

Newsletter delivered by beehiiv. See our privacy policy.